ONCO-INNOVATIONS LTD. Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Onco-Innovations reports quarterly EPS of -0.06 CAD

Onco-Innovations released figures for the quarter ended July 31, 2026, and reported earnings per share of -0.06 CAD. In the same quarter a year earlier, EPS was -0.050 CAD. » More on finanzen.net

Financials

In the last quarter, ONCO-INNOVATIONS LTD. Aktie had revenue of €0 and net profit of -€1.88M

(EUR)	January 2026	YoY
Revenue	0	-
Gross profit	0	-
Net profit	-1.88M	-
EBITDA	-1.88M	-

Fundamentals

Metric	Value
Market capitalization	€17.89M
Number of shares	43.38M
52-week high/low	€1.78 - €0.32
Dividends	No
Beta	8.62
P/E ratio	-
PEG ratio	-
P/B ratio	-
P/S ratio	-

Company profile

Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. Its product includes the ONC010 for cancer treatments. The company was founded on September 16, 2021 and is headquartered in Calgary, Canada.